查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386202

白喉疫苗市场报告：2030 年趋势、预测与竞争分析

Diphtheria Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

白喉疫苗趋势和预测

预计到 2030 年，全球白喉疫苗市场将达到 75 亿美元，2024 年至 2030 年年复合成长率为 6.5%。该市场的主要驱动因素是对组合疫苗的需求不断增加、人们对白喉疫苗接种重要性的认识不断提高以及政府不断倡议促进白喉疫苗接种计划。全球白喉疫苗市场前景看好，医院、诊所和疫苗接种中心市场有商机。

白喉疫苗市场洞察

Lucintel 预测，预防白喉、破伤风和百日咳的 DTaP 疫苗因其广泛使用，仍将是最大的细分市场。

医院可能仍然是该市场中最大的部分，因为它们是接受白喉疫苗接种的常见场所。

由于未接种疫苗的人群中白喉病例的增加以及该地区主要製造商的存在，预计北美在预测期内将出现最高的增长。

市场规模/估计：以金额的白喉疫苗市场规模估计（10 亿美元）。

趋势和预测分析：各个细分市场和地区的市场趋势（2018-2023）和预测（2024-2030）。

細項分析：按疫苗类型、最终用途和金额区域（十亿美元）估计白喉疫苗市场规模。

区域分析：北美、欧洲、亚太地区和世界其他地区、中东和非洲白喉疫苗市场细分。

成长机会：按疫苗类型、最终用途和地区分析白喉疫苗市场的成长机会。

策略分析：白喉疫苗市场併购、新产品开发、竞争形势等。

基于波特五力模型的产业竞争实力分析。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球白喉疫苗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球白喉疫苗市场趋势（2018-2023）与预测（2024-2030）
  • 按疫苗类型分類的全球白喉疫苗市场
    • 百白破疫苗
    • DT疫苗
    • 百日咳疫苗
    • 结核病疫苗
  • 全球白喉疫苗市场（依最终用途）
    • 医院
    • 诊所
    • 疫苗接种中心
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球白喉疫苗市场区域分布
  • 北美白喉疫苗市场
  • 欧洲白喉疫苗市场
  • 亚太白喉疫苗市场
  • 其他地区白喉疫苗市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按疫苗类型分類的全球白喉疫苗市场成长机会
    • 全球白喉疫苗市场成长机会（依最终用途）
    • 全球白喉疫苗市场成长机会（按地区）
  • 全球白喉疫苗市场的新趋势
  • 战略分析
    • 新产品开发
    • 全球白喉疫苗市场产能扩张
    • 全球白喉疫苗市场的合併、收购和合资企业
    • 认证和许可

第7章主要企业概况

  • AJ Vaccines
  • BIONET
  • Glaxosmithkline
  • MassBiologics
  • Merck & Co
  • Panacea Biotech
  • Sanofi
  • Serum Institute India
  • Bharat Biotech
  • Meiji
简介目录

Diphtheria Vaccine Trends and Forecast

The future of the global diphtheria vaccine market looks promising with opportunities in the hospital, clinic, and vaccination center markets. The global diphtheria vaccine market is expected to reach an estimated $7.5 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are increasing demand for combination vaccines, rising awareness of the importance of diphtheria vaccination, and growing government initiatives to promote diphtheria vaccination programs.

A more than 150-page report is developed to help in your business decisions.

Diphtheria Vaccine by Segment

The study includes a forecast for the global diphtheria vaccine by vaccine type, end use, and region.

Diphtheria Vaccine Market by Vaccine Type [Shipment Analysis by Value from 2018 to 2030]:

  • Dtap Vaccine
  • Dt Vaccine
  • Tdap Vaccine
  • Td Vaccine

Diphtheria Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Clinics
  • Vaccination Centers
  • Others

Diphtheria Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Diphtheria Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies diphtheria vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the diphtheria vaccine companies profiled in this report include-

  • AJ Vaccines
  • BIONET
  • Glaxosmithkline
  • Massbiologics
  • Merck & Co
  • Panacea Biotech
  • Sanofi
  • Serum Institute India
  • Bharat Biotech
  • Meiji

Diphtheria Vaccine Market Insights

Lucintel forecasts that DTaP vaccine will remain the largest segment due to its wide usage to protects against diphtheria, tetanus, and pertussis.

Within this market, hospital will remain the largest segment as it's a common places where people get vaccinated against diphtheria.

North America is expected to witness highest growth over the forecast period due to rising cases of diphtheria among unvaccinated people and presence of key manufacturers in the region.

Features of the Global Diphtheria Vaccine Market

Market Size Estimates: Diphtheria vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Diphtheria vaccine market size by vaccine type, end use, and region in terms of value ($B).

Regional Analysis: Diphtheria vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different vaccine types, end uses, and regions for the diphtheria vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the diphtheria vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the diphtheria vaccine market size?

Answer: The global diphtheria vaccine market is expected to reach an estimated $7.5 billion by 2030.

Q.2 What is the growth forecast for diphtheria vaccine market?

Answer: The global diphtheria vaccine market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the diphtheria vaccine market?

Answer: The major drivers for this market are increasing demand for combination vaccines, rising awareness of the importance of diphtheria vaccination, and growing government initiatives to promote diphtheria vaccination programs.

Q4. What are the major segments for diphtheria vaccine market?

Answer: The future of the diphtheria vaccine market looks promising with opportunities in the hospital, clinic, and vaccination center markets.

Q5. Who are the key diphtheria vaccine market companies?

Answer: Some of the key diphtheria vaccine companies are as follows:

  • AJ Vaccines
  • BIONET
  • Glaxosmithkline
  • Massbiologics
  • Merck & Co
  • Panacea Biotech
  • Sanofi
  • Serum Institute India
  • Bharat Biotech
  • Meiji

Q6. Which diphtheria vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that DTaP vaccine will remain the largest segment due to its wide usage to protects against diphtheria, tetanus, and pertussis.

Q7. In diphtheria vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to rising cases of diphtheria among unvaccinated people and presence of key manufacturers in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the diphtheria vaccine market by vaccine type (DTaP vaccine, DT vaccine, Tdap vaccine, and Td vaccine), end use (hospitals, clinics, vaccination centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Diphtheria Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Diphtheria Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Diphtheria Vaccine Market by Vaccine Type
    • 3.3.1: DTaP Vaccine
    • 3.3.2: DT Vaccine
    • 3.3.3: Tdap vaccine
    • 3.3.4: Td vaccine
  • 3.4: Global Diphtheria Vaccine Market by End Use
    • 3.4.1: Hospitals
    • 3.4.2: Clinics
    • 3.4.3: Vaccination centers
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Diphtheria Vaccine Market by Region
  • 4.2: North American Diphtheria Vaccine Market
    • 4.2.2: North American Diphtheria Vaccine Market by End Use: Hospitals, Clinics, Vaccination centers, and Others
  • 4.3: European Diphtheria Vaccine Market
    • 4.3.1: European Diphtheria Vaccine Market by Vaccine Type: DTaP Vaccine, DT Vaccine, Tdap vaccine, and Td vaccine
    • 4.3.2: European Diphtheria Vaccine Market by End Use: Hospitals, Clinics, Vaccination centers, and Others
  • 4.4: APAC Diphtheria Vaccine Market
    • 4.4.1: APAC Diphtheria Vaccine Market by Vaccine Type: DTaP Vaccine, DT Vaccine, Tdap vaccine, and Td vaccine
    • 4.4.2: APAC Diphtheria Vaccine Market by End Use: Hospitals, Clinics, Vaccination centers, and Others
  • 4.5: ROW Diphtheria Vaccine Market
    • 4.5.1: ROW Diphtheria Vaccine Market by Vaccine Type: DTaP Vaccine, DT Vaccine, Tdap vaccine, and Td vaccine
    • 4.5.2: ROW Diphtheria Vaccine Market by End Use: Hospitals, Clinics, Vaccination centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Diphtheria Vaccine Market by Vaccine Type
    • 6.1.2: Growth Opportunities for the Global Diphtheria Vaccine Market by End Use
    • 6.1.3: Growth Opportunities for the Global Diphtheria Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Diphtheria Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Diphtheria Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Diphtheria Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: AJ Vaccines
  • 7.2: BIONET
  • 7.3: Glaxosmithkline
  • 7.4: MassBiologics
  • 7.5: Merck & Co
  • 7.6: Panacea Biotech
  • 7.7: Sanofi
  • 7.8: Serum Institute India
  • 7.9: Bharat Biotech
  • 7.10: Meiji